Nihon University · Department of Medicine / Faculty of Medicine

Research keywords転移性前立腺癌・去勢抵抗性前立腺癌・アンドロゲン受容体・BRCA2変異前立腺癌・PARP阻害薬・ロボット支援前立腺全摘・前立腺肥大症MIST・Rezum水蒸気治療・進行尿路上皮癌・骨盤臓器脱フレイル

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Physical, but not laboratory, treatment-related adverse events are associated with favorable outcomes of enfortumab vedotin for advanced urothelial carcinoma: A landmark analysis.2024 · International journal of urology : official journal of the Japanese Urological Association, 2024年11月
• Brain metastasis in a patient with BRCA2-mutated treatment-related neuroendocrine prostate carcinoma and long-term response to radiotherapy and Olaparib: A case report and literature review.2024 · Medicine, 2024年03月
• Oncologic and Functional Outcomes of Salvage Robot-Assisted Radical Prostatectomy: Report of the First 10 Cases.2024 · Current oncology (Toronto, Ont.), 2024年08月
• AKR1C3-negative high-risk metastatic castration-sensitive prostate cancer has long-term response to first-line treatment with abiraterone: Four case reports.2024 · Urology case reports, 2024年05月

• 神経内分泌前立腺癌の病態メカニズム解明とその応用に向けた免疫反応からのアプローチ2024
• エピゲノムに基づく難治性前立腺癌の治療抵抗性機構の解明とその治療への応用2023
• 未治療転移性前立腺癌に対する内分泌化学免疫療法のプレシジョンメディシンの実現2023
• 去勢抵抗性前立腺がんのアンドロゲン受容体転写協調因子を標的としたポリアミド創薬2019

• Official profile